31 patents currently held
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Aug 2027. from the record
Of the 10 now held by other companies, 2 name Qiagen GmbH as their current owner, and 8 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Aug 2027
Next term end
26
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2032 · High confidence
Also notable
Ends Apr 2033 · High confidence
Also notable
Ends Apr 2034 · High confidence
System for Assessing Tissue Substance Extraction
US 10,792,000
The most cited patent in this portfolio, cited by 29 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2032.
High Expression Cereal Phytase Gene
US 9,540,633
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2033.
Compositions for Use in Restoring Muscle Glycogen and/or Muscle Mass
US 9,872,871
The largest patent family in this portfolio, 20 related applications, renewed at every maintenance window due so far. Protection runs to 2034.
Formerly held, still cited
Notable
Ends Oct 2033 · High confidence
The most cited patent in this portfolio, cited by 76 later US patents, top 5% of utility patents granted in 2018 in our data. Protection runs to 2033.
now held by Herlev Hospital
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 19 to 23, 2026 · next Nov 19
- 2 fees due Dec 6 to 25, 2026 · next Dec 6
- 1 fee due Feb 20, 2027The maintenance fee for Method for Determining Clinically Relevant Hypoxia in Cancer (US 10,385,399) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
Recent changes
- Oct 22Assignment recorded on 1 record: Sadeghi, Maryam and 3 others to Aarhus Universitet Recorded Oct 22, 2026, executed Mar 11, 2025. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76466, frame 610.
- Oct 8Assignment recorded on 1 record: Zelikin, Alexander N. and 4 others to Aarhus Universitet Recorded Oct 8, 2026, executed Sep 18, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76302, frame 337.
- 2 of the patents on this record were granted since Aug 17, 2026
- 1 term has ended since Aug 17, 2026
What they patent
The 5 largest of its 26 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Single Domain Antibodies for Complement Regulation | 3 in force | to Aug 2041 |
| Compounds for Use in Regulating Follicle Maturation | 2 in force | to Feb 2040 |
| Rufinamide for Use in the Treatment of Myotonia | 2 in force | to Dec 2036 |
| Compositions for Use in Restoring Muscle Glycogen and/or Muscle Mass | 2 in force | to Aug 2035 |
| Displacers of Ige-Fceri | 1 in force | to Jun 2043 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,003,002 | P-Type Thermoelectric Materials, a Process for Their Manufacture and Uses Thereof In force · High confidence | In force | High confidence | |
| US 8,911,937 | Method for detecting methylation status by using methylation-independent primers In force · High confidence | In force | High confidence | |
| US 9,036,878 | Method for Delineation of Tissue Lesions In force · High confidence | In force | High confidence | |
| US 10,792,000 | System for Assessing Tissue Substance Extraction held by Aarhus Universitet and Region Midtjylland In force · High confidence | In force | High confidence | |
| US 10,385,399 | Method for Determining Clinically Relevant Hypoxia in Cancer In force · High confidence | In force | High confidence | |
| US 9,540,633 | High Expression Cereal Phytase Gene In force · High confidence | In force | High confidence | |
| US 9,872,871 | Compositions for Use in Restoring Muscle Glycogen and/or Muscle Mass In force · High confidence | In force | High confidence | |
| US 10,328,048 | Cafestol for Treating Diabetes held by Aarhus Universitet and Region Midtjylland In force · High confidence | In force | High confidence | |
| US 10,166,253 | Positively Charged Co-Polymers for Use as Antimicrobial Agents In force · High confidence | In force | High confidence | |
| US 9,922,444 | Image Processing Apparatus and Method held by Samsung Electronics Co., Ltd. and Aarhus Universitet In force · High confidence | In force | High confidence |
Also on record, not counted in the 31: 10 patents in force now held by others · 35 patents ended · 69 applications pending · 114 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.